cGVHD
Immunology·MeSH: Bronchiolitis Obliterans Syndrome
2 drugs in development·2 companies·5 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| Niktimvo | Syndax Pharmaceuticals Inc (SNDX) |
BLA Filed(1)
| Drug | Company |
|---|---|
| belumosudil | Kadmon Holdings, Inc. (KDMN) |
Compare drugs
Frequently asked questions
How many drugs are in development for cGVHD?
BioSniper tracks 2 drugs in development for cGVHD across 2 companies.
How many clinical trials target cGVHD?
There are 5 clinical trials targeting cGVHD tracked by BioSniper.
Deep-dive into cGVHD
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis